These tests are for those who are asymptomatic and want to know if they have the virus or had it.
The COVID-19 IgG/IgM antibody test is a 15-minute instant point-of-care test devise for the qualitative detection of IgG and IgM antibodies specific to 2019-nCoV in human whole blood performed by a finger prick. They are 99% accurate for positive results and 89% accurate for negative results.*
It is $79 per test. Supplies are limited, orders are on a first-come first-serve basis, and no refunds.
The CDC recommends people with positive tests or negative tests with symptoms can end quarantine when they have had 72 hours fever free with no fever reducers, symptoms including cough are resolved and it has been at least seven days since the symptoms started.
- Pending emergency use authorization by the FDA.
- Though, this test has not been reviewed by the FDA, it has received emergency use authorization for diagnostic tests, and is being offered under the FDA’s Policy for Diagnostic Tests for Coronavirus Disease – 2019, Section IV.D
- Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
- Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
- Early infections may not have generated sufficient antibodies to be positive on the test.
- Currently it is not known if having any IgG antibodies indicates immunity; however, having IgG antibodies does indicate having had the infection
- Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
- *There is a 11% false negative rate (Out of 100 people with the disease up to 11 may falsely test negative).